Name: UMIN ID:
Unique ID issued by UMIN | UMIN000027523 |
---|---|
Receipt number | R000031499 |
Scientific Title | Noncontrolled open-label exploratory clinical trial of additional infliximab therapy for patients with refractory Kawasaki disease who are refractory to intravenous immunoglobulin therapy, additional intravenous immunoglobulin therapy and first infliximab therapy. |
Date of disclosure of the study information | 2017/06/01 |
Last modified on | 2020/05/31 19:24:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/05/29 09:32:44 | ||
2 | Update | 2019/06/02 09:49:43 | Recruitment status Date of IRB Last follow-up date |
|
3 | Update | 2019/06/02 09:53:06 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
4 | Update | 2020/05/31 19:23:14 | Number of participants that the trial has enrolled Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
5 | Update | 2020/05/31 19:24:19 | Recruitment status |